The board of directors of China NT Pharama Group Company Limited announced the following changes in composition of the Board. Redesignation of Director: Ms. Chin Yu (Ms. Chin) will be re-designated from an executive Director to a non-executive Director with effect from 15 January 2024. Ms. Chin, co-founder of the Group.

She has been an executive Director since February 2015 and responsible for the Group's daily operations. Ms. Ng, Anna Ching Mei (Ms. Ng) has been appointed as an executive Director of the Company with effect from 15 January 2024. She is the daughter of Mr. Ng and Ms. Chin, a executive Director, co-founder of the Group and the substantial shareholder of the Company.

She also is niece of Dr. Qian Wei, a non-executive Director. The biographical details of Ms. Ng is set out below: Ms. Ng, age 25, graduated from MSc Healthcare at University College London. She has 3 years working experience on laboratory experimental research with professor in Medicine and Biological Information Engineering department of Northeastern University Shenyang China.

Ms. Ng has published 2 journals on Chinese Academy of Sciences and declared the exclusive right by The China national patent office of these journals. Ms. Ng has ample experience in medicine and biological information engineering.